| Execution period | One year (renewable) |
|---|
BSE filing, NSE: PCJEWELLER. Summary written from the filing by ALFA Finder's alert engine.
PC Jeweller Ltd: key numbers
- Share price
- ₹14.69
- Market cap
- ₹14,408 Cr
- Revenue (annual)
- ₹3,353 Cr
- Net profit (annual)
- ₹714.5 Cr
- P/E (TTM)
- 16.1×Sector 33.3×
- Promoter holding
- 39.10%+0.61% QoQ
- FII holding
- 10.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PC Jeweller Ltd
All →PC Jeweller Legal & Regulatory
SEBI issued administrative warning letters to PC Jeweller's promoter MD and Company Secretary. The warnings concern failure to maintain a structured digital database for a quarterly business update.
PC Jeweller Capital Structure Change
UNICO Global Opportunities Fund, a non-promoter, sold 13.86 crore PC Jeweller shares in market sales from July to October 2026. Its stake fell from 4.97% to 2.97%.
PC Jeweller Other Announcement
PC Jeweller filed a Regulation 32 statement confirming there is no deviation in the utilization of proceeds from its preferential share and warrant issues.
PC Jeweller Investor Presentation: Key Takeaways
PC Jeweller reported strong Q2FY27 results with 28% revenue growth and achieved debt-free status. Strategy shifts toward retail expansion, franchise models, and a new Gen-Z focused brand.
PC Jeweller Q2 FY27 Results: Net Profit ₹330.7 Cr, Up 57.9% YoY
PC Jeweller Ltd reported revenue from operations of ₹1,054 Cr (+27.8% YoY) and net profit of ₹330.7 Cr (+57.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹330.7 Cr · +57.9% YoY
PC Jeweller Board Meeting Date
PC Jeweller Limited has scheduled a board meeting for October 21, 2026, to consider and approve its un-audited standalone and consolidated financial results.
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031